Marked hyperbilirubinemia associated with the heme oxygenase-1 gene promoter microsatellite polymorphism in a boy with autoimmune hemolytic anemia

Pediatrics. 2007 Mar;119(3):e764-7. doi: 10.1542/peds.2006-1385. Epub 2007 Feb 26.

Abstract

Mild hyperbilirubinemia is a clinical feature of hemolysis. Here we describe a boy with marked elevation of serum bilirubin values (maximum: 70 mg/dL) during an acute episode of autoimmune hemolytic anemia, which returned to within the reference range after clinical improvement. The boy was a homozygous carrier of short alleles of the heme oxygenase-1 (HO-1) gene GT dinucleotide-repeat promoter polymorphism, which is associated with increased activity and inducibility of the heme-degrading enzyme HO-1, which catalyzes the production of bilirubin. In addition, heterozygosity of the uridine 5'-diphosphate-glucuronosyl-transferase 1A1 promoter polymorphism that is linked with Gilbert syndrome was found in this patient. Because bilirubin production plays a critical role during the neonatal period, the HO-1 promoter polymorphism may be an important genetic factor for the clinical outcome of neonatal hyperbilirubinemia.

Publication types

  • Case Reports

MeSH terms

  • Adolescent
  • Anemia, Hemolytic, Autoimmune / complications*
  • Anemia, Hemolytic, Autoimmune / drug therapy
  • Cyclosporine / therapeutic use
  • Genotype
  • Heme Oxygenase-1 / genetics*
  • Humans
  • Hyperbilirubinemia / blood
  • Hyperbilirubinemia / diagnosis
  • Hyperbilirubinemia / genetics*
  • Hyperbilirubinemia / therapy
  • Immunosuppressive Agents / therapeutic use
  • Male
  • Microsatellite Repeats / genetics*
  • Polymorphism, Genetic / genetics*
  • Splenectomy
  • Treatment Outcome

Substances

  • Immunosuppressive Agents
  • Cyclosporine
  • Heme Oxygenase-1